A blood test measuring donor-derived cell-free DNA (dd-cfDNA) is now emerging as a promising tool for earlier detection of transplant complications. The technology enables earlier detection of organ injury and may reduce the need for invasive biopsies, according to the recent publication “Utilizing Cell-Free DNA Technologies for Clinically Significant Biomarkers in Solid Organ Transplantation.”
For the full article click here: Blood Test Tracks Transplant Health Using Donor DNA